Why Family Caregivers Should Care for their Families' Genetic Inheritance Data
By Dr. Gordon Atherley,
Voice America
| 02. 10. 2014
[With CGS's Marcy Darnovsky]
Marcy Darnovsky, PhD, is Executive Director of the
Center for Genetics and Society.
Jeff Nisker, MD PhD FRCSC
FCAHS, is a Professor of Obstetrics-Gynaecology at the Schulich School
Medicine & Dentistry, Western University, and Scientist, Children’s
Health Research Institute. They
highlight their lives, careers and experience with family caregiving.
They describe their work with their organizations. They discuss the
benefits and risks associated with the use of families’ genetic
inheritance data for research and for medical treatment. They explain
why, and how, family caregivers should care for their families’ genetic
inheritance data when it is used for research or for medical treatment.
They say what more they would like to do and see done by government
privacy agencies, hospitals and physicians to help family caregivers
care for their families’ genetic inheritance.
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...